𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Coronary Stents in the Animal Model: A Review

✍ Scribed by H. Wieneke; M. Haude; M. Knocks; A. Gutersohn; C. von Birgelen; D. Baumgart; R. Erbel


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
70 KB
Volume
30
Category
Article
ISSN
0933-5137

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Coronary artery stenting for spontaneous
✍ Vale, Peter R. ;Baron, David W. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 322 KB πŸ‘ 2 views

Spontaneous coronary artery dissection is an uncommon cause of acute coronary syndromes. It occurs in three major groups: in young women in the peripartum period, in patients with atherosclerotic disease, and in an idiopathic group. There are a number of associated conditions, but the pathogenesis r

ISR II study: A long-term evaluation of
✍ Philippe Commeau; Paul T. Barragan; Pierre O. Roquebert; Jean B. SimΓ©oni πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 1 views

The aim of this pilot study was to determine the safety and long-term efficacy of treating intrastent restenosis (ISR) with the slow-release sirolimus-eluting stent Bx Velocity (Cypher stent) without intravascular ultrasound (IVUS) guidance. Of patients who received a bare metal stent implantation a

A unique pitfall in percutaneous coronar
✍ Deepak Jain; Volkhard Kurowski; Hugo A. Katus; Gert Richardt πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 177 KB πŸ‘ 1 views

## Abstract Three cases of in‐stent restenosis are narrated, wherein, during balloon angioplasty of the lesion, the guidewire inadvertently exited out of the stent. The forward balloon progress was halted in this region. In the first case, the situation could only be realized when dilatation of a f

An evaluation of the GABA uptake blocker
✍ William J. Giardina; Michael W. Decker; Roger D. Porsolt; Sylvain Roux; Stephen πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

Tiagabine HCl [(R]-N-[4,4-bis(3-methyl-2-thienyl]-3-butenyl] nipecotic acid hydrochloride], a potent and selective GABA uptake inhibitor, was evaluated for potential anti-allodynic effects in a rodent model of neuropathic pain and for antinociceptive activity in rodent models of acute and persistent